Skip to main content
. Author manuscript; available in PMC: 2014 Sep 24.
Published in final edited form as: ACS Nano. 2013 Aug 20;7(9):7724–7733. doi: 10.1021/nn4023119

Figure 11.

Figure 11

Biodistribution of DOX-SPIOs in tumor and liver tissue following combination therapy (nano-embolization followed by nano-ablation) in VX2 rabbit model. Combination therapy resulted in significantly increased delivery to both the tumor core and periphery, compared to nano-embolization alone (p<0.05). Furthermore, a significant difference in off-target delivery, to healthy liver tissue, was not observed (p=ns).